CytomX Therapeutics, Inc. announced that in connection with the company's restructuring plans and reduction to its workforce, the employment of Amy Peterson, M.D., the Company's President and Chief Operating Officer, is expected to terminate effective September 12, 2022, and the employment of Carlos Campoy, the Company's SVP, Chief Financial Officer, and Alison Hannah, M.D., the Company's SVP, Chief Medical Officer, is expected to terminate effective as of September 30, 2022.